|Articles|April 1, 1999

A Multidisciplined Approach to Improving the Treatment of Allergic Rhinitis in the Managed Care Popu
Volume 5
Issue 4 Suppl

Economic Outcomes of a Targeted Intervention Program: The Costs of Treating Allergic Rhinitis Patients

Author(s)Richard Santos, PhD, Mary Cifaldi, RPh, MSHA, Cindy Gregory, PhD

Download PDF: Economic Outcomes of a Targeted Intervention Program: The Costs of Treating Allergic Rhinitis Patients

Articles in this issue

over 26 years ago

Article

Participating Faculty

over 26 years ago

Article

Selected Abstracts

over 26 years ago

Article

Bibliography

over 26 years ago

Article

The Role of the ECHO Model in Outcomes Research and Clinical Practice Improvement

over 26 years ago

Article

Effect of Fexofenadine HC1 on Quality of Life and Work, Classroom, and Daily Activity Impairment in Patients with Seasonal Allergic Rhinitis

over 26 years ago

Article

Diagnosis and Treatment of Allergic Rhinitis: Primary Care in an Integrated Health System Setting

over 26 years ago

Article

CME Quiz

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Subscribe Now!

Related Content

HEDIS Glycemic Goal Achieved Using Control-IQ Technology

ByBimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Miranda R. Polin, MS, BS,Irl B. Hirsch, MD,Laya Ekhlaspour, MD,Steve Edelman, MD,Diana I. Brixner, PhD, RPh,Charles Stemple, DO

December 22nd 2025

Linking Data to Determine Risk for 30-Day Readmissions in Dementia

ByPamela S. Roberts, PhD, OTR/L,Chih-Ying Li, PhD, OTR/L,Debra S. Ouellette, MS, OTR/L,Nabeel Qureshi, MPH,Erica Spivack, MHA,Mary Nasmyth, MD,Nancy L. Sicotte, MD,Zaldy S. Tan, MD

December 22nd 2025

Performance of 2-Stage Health-Related Social Needs Screening Using Area-Level Measures

ByJoshua R. Vest, PhD, MPH,Christopher A. Harle, PhD,Justin Blackburn, PhD

December 19th 2025

Impact of Medicaid Institution for Mental Diseases Exclusion on Serious Mental Illness Outcomes

ByOnur Baser, PhD, MS,Heidi C. Waters, PhD,Nehir Yapar, BS,Katarzyna Rodchenko, MA, MPH,Lauren Isenman, MPH,Xue Han, PhD,Deborah Freedman, MBA,Rashmi Patel, MD, PhD

December 17th 2025

Physician-Pharmacy Integration in Cancer Care: Pillars of Medically Integrated Pharmacy

ByGury K. Doshi, MD,Lucio Gordan, MD,Kirollos Hanna, PharmD,Scott Freeswick, PharmD,Natalie Dickson, MD,Desi Kotis, PharmD,Osama Abdelghany, PharmD, MHA,Ken Komorny, PharmD,Neal Dave, PharmD,Michael Reff, RPh, MBA

Economic Outcomes of a Targeted Intervention Program: The Costs of Treating Allergic Rhinitis Patients

Articles in this issue

Newsletter

Related Content

HEDIS Glycemic Goal Achieved Using Control-IQ Technology

Linking Data to Determine Risk for 30-Day Readmissions in Dementia

Performance of 2-Stage Health-Related Social Needs Screening Using Area-Level Measures

Impact of Medicaid Institution for Mental Diseases Exclusion on Serious Mental Illness Outcomes

Physician-Pharmacy Integration in Cancer Care: Pillars of Medically Integrated Pharmacy

Trending on AJMC

Visibility, Not Lesion Burden, Drives Distress in Alopecia Areata

Top 5 Most-Read CLL Articles of 2025

Evidence Suggests Bidirectional Risk Between Ovarian, Colorectal Cancers

Top 5 Most-Read CRC Content in 2025

Top 5 Most-Read "5 Things" Articles of 2025